acetylcysteine (Paddock Laboratories, LLC)
Welcome to the PulseAid listing for the acetylcysteine drug offered from Paddock Laboratories, LLC. This Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Paddock Laboratories, LLC |
| NON-PROPRIETARY NAME: | Acetylcysteine |
| SUBSTANCE NAME: | ACETYLCYSTEINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-20 |
| END MARKETING DATE: | 0000-00-00 |
acetylcysteine HUMAN PRESCRIPTION DRUG Details:
| Item Description | acetylcysteine from Paddock Laboratories, LLC |
| LABELER NAME: | Paddock Laboratories, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/mL) |
| START MARKETING DATE: | 2012-12-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0574-0805_db426741-70c9-4512-b562-2d4b8e39f034 |
| PRODUCT NDC: | 0574-0805 |
| APPLICATION NUMBER: | NDA021539 |
Other ACETYLCYSTEINE Pharmaceutical Manufacturers / Labelers:
